Root Financial Partners
CTNM icon

Root Financial Partners’s Contineum Therapeutics CTNM Stock Holding History

Root Financial Partners’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13 Buy
+1
New +$15 ﹤0.01% 3799

Other funds holding CTNM

Red Tree Management
Red Tree Management Redwood City, California $117M AUM 89.68% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners's CTNM Position: Q3 2026 in Review

Root Financial Partners opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 1 share worth $13. The stake represents ﹤0.01% of the portfolio and ranks #3799 among its holdings.

8 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Root Financial Partners held 1 share of Contineum Therapeutics worth $13 as of Q3 2026.
  • Contineum Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3799 holding.
  • 8 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.